Bulletin
Investor Alert

London Markets Open in:

Market Pulse Archives

June 30, 2022, 8:51 a.m. EDT

Aura's stock jumps 11% after announcing Fast Track status for its bladder cancer treatment candidate

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Aura Biosciences Inc. (AURA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Aura Biosciencs Inc. /zigman2/quotes/230573529/composite AURA +3.92% were up 11.3% in premarket trading on Thursday after the company said it received a Fast-Track designation from the Food and Drug Administration for its experimental bladder-cancer treatment. Aura is planning to start the Phase 1 clinical trial for this indication in 2023. The company's stock is down 25.9% this year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX +2.13% has declined 19.9%.

/zigman2/quotes/230573529/composite
US : U.S.: Nasdaq
$ 19.08
+0.72 +3.92%
Volume: 82,748
Aug. 10, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$537.21 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,210.24
+87.77 +2.13%
Volume: 2.22B
Aug. 10, 2022 5:27p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.